| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.00098 | 1 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.00077 | 1 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.00089 | 1 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.00077 | 1 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.0031 | 1 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.00049 | 1 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.00046 | 1 |